Tempus AI is a pioneering healthcare technology company focused on advancing precision medicine through the application of artificial intelligence. Founded in 2015 in Chicago, Tempus integrates genomic sequencing, molecular data, and clinical information to empower physicians to deliver personalized care, especially in oncology, cardiology, radiology, and mental health. Its AI-driven platform helps optimize diagnostics, treatment decisions, and clinical research by analyzing vast amounts of health data. Tempus collaborates widely with healthcare providers, pharmaceutical companies, and research institutions, aiming to improve patient outcomes and accelerate the discovery of new therapies.
Key Features:
AI-powered genomic sequencing and diagnostics delivering personalized treatment insights.
Large multimodal data library combining genetics, pathology, radiology, and electronic health records.
Intelligent applications such as clinical assistants, treatment monitoring tools, and real-time data analytics.
Strategic collaborations for drug development, clinical trial matching, and advanced research capabilities.
Use Cases:
Tailoring cancer treatment plans based on tumor genetic profiles.
Accelerating pharmaceutical research and clinical trial matching.
Enhancing diagnostic accuracy across multiple medical specialties using AI insights.